Sites of thrombosis and major hemorrhage and treatment received by patients
| Variable . | No. (%) . |
|---|---|
| Sites of thrombosis | |
| Cerebral venous sinus thrombosis | 67 (45) |
| Intracerebral/subarachnoid hemorrhage | 35 (23) |
| Arterial (eg, limb ischemia and stroke) | 32 (21) |
| Lower extremity deep venous thrombosis | 17 (11) |
| Pulmonary embolus | 40 (27) |
| Splanchnic vein thrombosis (eg, mesenteric, portal, and hepatic) | 23 (16) |
| Treatment received | |
| Intravenous immunoglobulin | 108 (73) |
| Systemic corticosteroids (oral prednisolone/ dexamethasone or intravenous methylprednisolone) | 85 (57) |
| Nonheparin anticoagulation (eg, fondaparinux, argatroban, and direct-acting oral anticoagulants) | 106 (72) |
| Low-molecular-weight heparin | 24 (16) |
| Unfractionated heparin | 8 (5) |
| Surgical/interventional radiology intervention | 19 (13) |
| Platelet transfusion | 16 (11) |
| PEX | 18 (12) |
| Variable . | No. (%) . |
|---|---|
| Sites of thrombosis | |
| Cerebral venous sinus thrombosis | 67 (45) |
| Intracerebral/subarachnoid hemorrhage | 35 (23) |
| Arterial (eg, limb ischemia and stroke) | 32 (21) |
| Lower extremity deep venous thrombosis | 17 (11) |
| Pulmonary embolus | 40 (27) |
| Splanchnic vein thrombosis (eg, mesenteric, portal, and hepatic) | 23 (16) |
| Treatment received | |
| Intravenous immunoglobulin | 108 (73) |
| Systemic corticosteroids (oral prednisolone/ dexamethasone or intravenous methylprednisolone) | 85 (57) |
| Nonheparin anticoagulation (eg, fondaparinux, argatroban, and direct-acting oral anticoagulants) | 106 (72) |
| Low-molecular-weight heparin | 24 (16) |
| Unfractionated heparin | 8 (5) |
| Surgical/interventional radiology intervention | 19 (13) |
| Platelet transfusion | 16 (11) |
| PEX | 18 (12) |
Patients may have had thrombus in multiple sites as well as receiving multiple treatment modalities.